Donna Skerrett has over 30 years of experience in the pharmaceutical industry, in transfusion medicine, cellular therapy and transplantation.
Dr Skerrett was the director of transfusion medicine and cellular therapy at Weill Cornell Medical Centre in New York from 2004 to 2011, and an associate director of transfusion medicine and director of stem cell facilities at Columbia University's New York-Presbyterian Hospital from 1999 to 2004. She has been an advisor to the New York State Department of Health on the Progenitor Cell Committee since 1989, and a board member of the Alliance for Regenerative Medicine since 2014.
Dr Skerrett joined Paradigm Biopharmaceuticals in September 2019 as chief medical officer, with her primary role to manage the company's clinical development programs across its entire indication pipeline.
